申请人:——
公开号:US20030092728A1
公开(公告)日:2003-05-15
Chemical compounds which are antagonists of Monocyte Chemoattractant Protein-1 (MCP-1) function, pharmaceutical compositions comprising these compounds, methods of treatment employing these compounds and compositions, and processes for preparing these compounds. The compounds are useful in the prevention or treatment of chronic or acute inflammatory or autoimmune diseases, especially those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, Orohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis, and transplant rejection.
以下是您请求的翻译结果:
对单核细胞趋化蛋白-1(MCP-1)功能具有拮抗作用的化学化合物,包含这些化合物的药物组合物,使用这些化合物和组合物进行治疗的方法,以及制备这些化合物的方法。这些化合物可用于预防或治疗慢性或急性炎症或自身免疫性疾病,尤其是那些与异常淋巴细胞或单核细胞积聚相关的疾病,如关节炎、哮喘、动脉粥样硬化、糖尿病肾病、炎症性肠病、克罗恩病、多发性硬化症、肾炎、胰腺炎、肺纤维化、银屑病、再狭窄和移植排斥。